S. 4302 · 117th Congress
Biologics Market Transparency Act of 2022
- Stage
- In committee
- Sponsor
- Tim Kaine
- Introduced
- 2022-05-25
- Latest action
- 2022-05-25 · Introduced in Senate
Summary
Biologics Market Transparency Act of 2022
This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.